Form 8-K - Current report:
SEC Accession No. 0001193125-25-028146
Filing Date
2025-02-18
Accepted
2025-02-18 07:07:50
Documents
13
Period of Report
2025-02-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d916580d8k.htm   iXBRL 8-K 27862
  Complete submission text file 0001193125-25-028146.txt   150905

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sldb-20250218.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20250218_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20250218_pre.xml EX-101.PRE 11263
15 EXTRACTED XBRL INSTANCE DOCUMENT d916580d8k_htm.xml XML 3643
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 25632719
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)